Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PD-1 Antikörper (AA 120-170)

Dieses Anti-PD-1-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von PD-1 in WB, ELISA, IF, IHC (p) und ICC. Geeignet für Human, Maus und Ratte.
Produktnummer ABIN6990726

Kurzübersicht für PD-1 Antikörper (AA 120-170) (ABIN6990726)

Target

Alle PD-1 (PDCD1) Antikörper anzeigen
PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

Reaktivität

  • 218
  • 103
  • 26
  • 5
  • 4
  • 3
Human, Maus, Ratte

Wirt

  • 120
  • 106
  • 52
  • 13
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Kaninchen

Klonalität

  • 223
  • 75
  • 5
Polyklonal

Konjugat

  • 152
  • 22
  • 14
  • 13
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PD-1 Antikörper ist unkonjugiert

Applikation

  • 161
  • 111
  • 95
  • 59
  • 47
  • 32
  • 29
  • 26
  • 21
  • 17
  • 13
  • 13
  • 13
  • 10
  • 10
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
  • Bindungsspezifität

    • 16
    • 16
    • 7
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 120-170

    Aufreinigung

    PD-1 Antibody is affinity chromatography purified via peptide column.

    Immunogen

    PD-1 antibody was raised against a 16 amino acid synthetic peptide from near the center of human PD-1. The immunogen is located within amino acids 120 - 170 of PD-1.

    Isotyp

    IgG
  • Applikationshinweise

    PD-1 antibody can be used for detection of PD-1 by Western blot at 1 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL and immunocytochemistry at 10 μ,g/mL. For immunofluorescence start at 10 μ,g/mL.

    Antibody validated: Western Blot in human samples, Immunohistochemistry in human samples, Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PD-1 Antibody is supplied in PBS containing 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,4 °C

    Informationen zur Lagerung

    PD-1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Target

    PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))

    Andere Bezeichnung

    PD-1

    Hintergrund

    PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases.

    Molekulargewicht

    Predicted: 32 kDa

    Observed: 43 kDa

    Gen-ID

    5133

    UniProt

    Q15116

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!